Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study, which aims to provide data on the efficacy and safety of HDM1002 tablets in adults with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise only

Timeline

Start

2025-08-12

Primary completion

2026-10-10

Completion

2027-02-01

Drugs

Indications